Press release
March 10, 2026
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
Filana Therapeutics, Inc. (FLNA)
New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating TSC-related epilepsy Filana Therapeutics to begin trading under “FLNA” effective March 11, 2026 AUSTIN, Texas, March 10, 2026 (GLOBE NEWSWIRE) -- Cassava